Artelo Biosciences, Inc. (ARTL) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Artelo Biosciences, Inc.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist,…
Source: Yahoo Finance
Sector & Industry
Artelo Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Artelo Biosciences, Inc. at a Glance
| Company | Artelo Biosciences, Inc. |
| Ticker | ARTL |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $6.04 |
| Market cap | $3.31M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$101.07 |
| 52-week high | $179.19 |
| 52-week low | $4.68 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | -0.07 |
| Return on equity (ROE) | -705.71% |
| Debt-to-equity | 0.98% |
| Average volume | 51,131 |
| Shares outstanding | 547,774 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 7 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Artelo Biosciences, Inc.'s current P/E ratio?
- Artelo Biosciences, Inc. (ARTL) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Artelo Biosciences, Inc.'s market capitalisation?
- Artelo Biosciences, Inc.'s market cap is $3.31M based on our latest snapshot. See how it ranks by market cap →
- What is ARTL's 52-week range?
- Over the past 52 weeks, ARTL has traded between $4.68 and $179.19. What does the 52-week range mean? →
- How volatile is Artelo Biosciences, Inc. compared to the market?
- Artelo Biosciences, Inc. has a beta of -0.07, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Artelo Biosciences, Inc. pay a dividend?
- Artelo Biosciences, Inc. does not currently pay a dividend according to our latest data.
- What exchange is ARTL listed on?
- ARTL is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Artelo Biosciences, Inc. in?
- Artelo Biosciences, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →